Inhibitor Therapeutics Inc (INTI): hedgepath provides final trial update an...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: None

Tuesday, 06/05/2018 10:26:54 AM

Tuesday, June 05, 2018 10:26:54 AM

hedgepath provides final trial update and announces type-C meeting with FDA in July 2018 for NDA for suba-itraconazole:

http://www.hedgepathpharma.com/

http://docs.wixstatic.com/ugd/041d82_ed9f4a168eaf4ebdb077306080e32e7b.pdf

Keep Last Read

Next 10 Prev Next

Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 01:30:38 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 05:34:39 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 05:34:37 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 05:34:35 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 05:34:32 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 05:34:29 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 01:00:44 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 11:02:01 AM
Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 01:54:52 PM

InvestorsHub NewsWire

Only $200 per official company press release!